These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25543253)

  • 1. Reduced curvature of ligand-binding domain free-energy surface underlies partial agonism at NMDA receptors.
    Dai J; Zhou HX
    Structure; 2015 Jan; 23(1):228-236. PubMed ID: 25543253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semiclosed Conformations of the Ligand-Binding Domains of NMDA Receptors during Stationary Gating.
    Dai J; Zhou HX
    Biophys J; 2016 Oct; 111(7):1418-1428. PubMed ID: 27705765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural mechanism of N-methyl-D-aspartate receptor type 1 partial agonism.
    Ylilauri M; Pentikäinen OT
    PLoS One; 2012; 7(10):e47604. PubMed ID: 23077649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural dynamics of the glycine-binding domain of the N-methyl-D-aspartate receptor.
    Dolino DM; Cooper D; Ramaswamy S; Jaurich H; Landes CF; Jayaraman V
    J Biol Chem; 2015 Jan; 290(2):797-804. PubMed ID: 25404733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heteromerization of ligand binding domains of N-methyl-D-aspartate receptor requires both coagonists, L-glutamate and glycine.
    Cheriyan J; Mezes C; Zhou N; Balsara RD; Castellino FJ
    Biochemistry; 2015 Jan; 54(3):787-94. PubMed ID: 25544544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic contributions to gating by interactions unique to N-methyl-D-aspartate (NMDA) receptors.
    Borschel WF; Cummings KA; Tindell LK; Popescu GK
    J Biol Chem; 2015 Oct; 290(44):26846-55. PubMed ID: 26370091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of NMDA receptors and the mechanism of inhibition by ifenprodil.
    Tajima N; Karakas E; Grant T; Simorowski N; Diaz-Avalos R; Grigorieff N; Furukawa H
    Nature; 2016 Jun; 534(7605):63-8. PubMed ID: 27135925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational analysis of NMDA receptor GluN1, GluN2, and GluN3 ligand-binding domains reveals subtype-specific characteristics.
    Yao Y; Belcher J; Berger AJ; Mayer ML; Lau AY
    Structure; 2013 Oct; 21(10):1788-99. PubMed ID: 23972471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanism of ligand recognition by NR3 subtype glutamate receptors.
    Yao Y; Harrison CB; Freddolino PL; Schulten K; Mayer ML
    EMBO J; 2008 Aug; 27(15):2158-70. PubMed ID: 18636091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of a heterotetrameric NMDA receptor ion channel.
    Karakas E; Furukawa H
    Science; 2014 May; 344(6187):992-7. PubMed ID: 24876489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Full and partial agonism of ionotropic glutamate receptors indicated by molecular dynamics simulations.
    Postila PA; Ylilauri M; Pentikäinen OT
    J Chem Inf Model; 2011 May; 51(5):1037-47. PubMed ID: 21500800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-Molecule Patch-Clamp FRET Anisotropy Microscopy Studies of NMDA Receptor Ion Channel Activation and Deactivation under Agonist Ligand Binding in Living Cells.
    Sasmal DK; Yadav R; Lu HP
    J Am Chem Soc; 2016 Jul; 138(28):8789-801. PubMed ID: 27270213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model structures of the N-methyl-D-aspartate receptor subunit NR1 explain the molecular recognition of agonist and antagonist ligands.
    Moretti L; Pentikäinen OT; Settimo L; Johnson MS
    J Struct Biol; 2004 Mar; 145(3):205-15. PubMed ID: 14960371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How does binding of agonist ligands control intrinsic molecular dynamics in human NMDA receptors?
    Palmai Z; Houenoussi K; Cohen-Kaminsky S; Tchertanov L
    PLoS One; 2018; 13(8):e0201234. PubMed ID: 30075003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular dynamics study-based mechanism of nefiracetam-induced NMDA receptor potentiation.
    Omotuyi OI; Ueda H
    Comput Biol Chem; 2015 Apr; 55():14-22. PubMed ID: 25659913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. All atom NMDA receptor transmembrane domain model development and simulations in lipid bilayers and water.
    Mesbahi-Vasey S; Veras L; Yonkunas M; Johnson JW; Kurnikova MG
    PLoS One; 2017; 12(6):e0177686. PubMed ID: 28582391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolutionary trace analysis of ionotropic glutamate receptor sequences and modeling the interactions of agonists with different NMDA receptor subunits.
    Blaise MC; Sowdhamini R; Rao MR; Pradhan N
    J Mol Model; 2004 Dec; 10(5-6):305-16. PubMed ID: 15597199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gating mechanism and a modulatory niche of human GluN1-GluN2A NMDA receptors.
    Wang H; Lv S; Stroebel D; Zhang J; Pan Y; Huang X; Zhang X; Paoletti P; Zhu S
    Neuron; 2021 Aug; 109(15):2443-2456.e5. PubMed ID: 34186027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular dynamics simulations of the ligand-binding domain of an N-methyl-D-aspartate receptor.
    Kaye SL; Sansom MS; Biggin PC
    J Biol Chem; 2006 May; 281(18):12736-42. PubMed ID: 16513640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural consequences of D481N/K483Q mutation at glycine binding site of NMDA ionotropic glutamate receptors: a molecular dynamics study.
    Blaise MC; Bhattacharyya D; Sowdhamini R; Pradhan N
    J Biomol Struct Dyn; 2005 Feb; 22(4):399-410. PubMed ID: 15588104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.